Explore By Subject Area   

Biogen Pilot on Using Vocal Biomarkers to Identify Potential Trial Participants: From the DPHARM 2024 Archives

Biogen discussed pilots in which they used an AI-enabled software to detect cognitive impairment and Alzheimer’s disease neuropathology, based on voice, to identify potential patients and reduce the burden of pre-screening.

September 26, 2025
Biogen Pilot on Using Vocal Biomarkers to Identify Potential Trial Participants: From the DPHARM 2024 Archives

In this podcast from the DPHARM 2024 archives, Biogen discussed pilots in which they used an AI-enabled software to detect cognitive impairment and Alzheimer’s disease neuropathology, based on voice, to provide access to patients with a clinically validated cognitive assessment who might not otherwise have the foundation to start a conversation with their physician about their cognition, and to reduce the burden of pre-screening. 

For more information, go to DPHARMconference.com.


Speakers

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.